Results 21 to 30 of about 4,742,503 (345)

Association between diabetes, diabetes treatment and risk of developing endometrial cancer. [PDF]

open access: yes, 2014
BackgroundA growing body of evidence suggests that diabetes is a risk factor for endometrial cancer incidence. However, most of these studies used case-control study designs and did not adjust for obesity, an established risk factor for endometrial ...
Beresford, S   +8 more
core   +2 more sources

The incidence and survival of cervical, ovarian, and endometrial cancer in Korea, 1999-2017: Korea Central Cancer Registry

open access: yesObstetrics & Gynecology Science, 2021
Objective The three major gynecologic cancers are cervical, endometrial, and ovarian cancer. This study aimed to describe the 19-year trends and survival rates in cervical, endometrial, and ovarian cancer in a Korean female population.
H. I. Ha   +5 more
semanticscholar   +1 more source

Οutcomes for patients who are diagnosed with breast and endometrial cancer [PDF]

open access: yes, 2013
The present study sought to determine the survival outcomes for women diagnosed with breast and endometrial cancer. Using SEER data, a population-based cohort study of women diagnosed with breast and endometrial cancer was conducted.
Margenthaler, Julie A   +2 more
core   +2 more sources

Clinical Activity and Safety of the Anti–Programmed Death 1 Monoclonal Antibody Dostarlimab for Patients With Recurrent or Advanced Mismatch Repair–Deficient Endometrial Cancer

open access: yesJAMA Oncology, 2020
Key Points Question What is the clinical antitumor activity and safety of dostarlimab for patients with deficient mismatch repair endometrial cancer? Findings In this nonrandomized phase 1 clinical trial, the confirmed objective response rate was 42%; 13%
A. Oaknin   +14 more
semanticscholar   +1 more source

Total tissue lactate dehydrogenase activity in endometrial carcinoma [PDF]

open access: yes, 2008
Lactate dehydrogenase (LDH) is essential for continuous glycolysis necessary for accelerated tumor growth. The aim of this study was to reconsider if assay of total tissue activity of this enzyme could be useful as marker for endometrial carcinoma (EC ...
Abramić, Marija   +4 more
core   +1 more source

Metformin as a Therapeutic Target in Endometrial Cancers. [PDF]

open access: yes, 2018
Endometrial cancer is the most common gynecologic malignancy in developed countries. Its increasing incidence is thought to be related in part to the rise of metabolic syndrome, which has been shown to be a risk factor for the development of ...
Johnson, Jennifer   +6 more
core   +2 more sources

Immunophenotype of Atypical Polypoid Adenomyoma of the Uterus: Diagnostic Value and Insight on Pathogenesis [PDF]

open access: yes, 2020
Atypical polypoid adenomyoma (APA) is a rare uterine lesion constituted by atypical endometrioid glands, squamous morules, and myofibromatous stroma. We aimed to assess the immunophenotype of the 3 components of APA, with regard to its pathogenesis and ...
Aggarwal   +46 more
core   +1 more source

Assessment of Sentinel Lymph Node Biopsy vs Lymphadenectomy for Intermediate- and High-Grade Endometrial Cancer Staging

open access: yesJAMA Surgery, 2020
Key Points Question What is the diagnostic accuracy of sentinel lymph node biopsy (SLNB) compared with lymphadenectomy in women with intermediate- and high-grade endometrial cancer?
M. Cusimano   +19 more
semanticscholar   +1 more source

Assessment of sexual difficulties associated with multi-modal treatment for cervical or endometrial cancer: A systematic review of measurement instruments [PDF]

open access: yes, 2016
Background: Practitioners and researchers require an outcome measure that accurately identifies the range of common treatment-induced changes in sexual function and well-being experienced by women after cervical or endometrial cancer.
Lucas, G.   +3 more
core   +1 more source

PORTEC-4a: international randomized trial of molecular profile-based adjuvant treatment for women with high-intermediate risk endometrial cancer

open access: yesInternational Journal of Gynecological Cancer, 2020
Background Vaginal brachytherapy is currently recommended as adjuvant treatment in patients with high-intermediate risk endometrial cancer to maximize local control and has only mild side effects and no or limited impact on quality of life.
A. S. V. M. van den Heerik   +29 more
semanticscholar   +1 more source

Home - About - Disclaimer - Privacy